Tepnel Life Sciences(TED)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE AIM All-Share

Market Cap

£29.17m

Change Today

Price Down-0.50p

Share Price

12.50p

Tomkins pair show faith

Date: Tuesday 18 Mar 2008

LONDON (ShareCast) - Engineer Tomkins generates around 60% of its sales in the US and concerns about the impact of a US recession have hit the share price hard.

Some respite came today with hefty purchases of shares by chief executive James Nicol and finance director James Zimmerman. Nicol bought just short of £200,000 worth of shares at 153p, while Zimmerman bought £67,000 worth. Nicol now owns 2.23m shares and Zimmerman 272,000.

Last month, Tomkins warned outlook on some of its markets remain challenging as it saw underlying profits fall for the year but added that it was accelerating a restructuring programme to save costs.

Top Director Buys
Tomkins (TOMK)
Director name: Mr James Nicol
Amount purchased: 129,684 @ 153.416p
Value: £198,956

Tomkins (TOMK)
Director name: Mr John Zimmerman
Amount purchased: 43,960 @ 153.416p
Value: £67,442

Canaccord Capital (CCI)
Director name: Mr Paul Reynolds
Amount purchased: 25,000 @ 457.92p
Value: £114,480

Canaccord Capital (CCI)
Director name: Mr Timothy J D Hoare
Amount purchased: 25,000 @ 456.91p
Value: £114,228

LSL Property Services (LSL)
Director name: Mr Simon Embley
Amount purchased: 80,000 @ 130.00p
Value: £104,000

CBG Group (CB.)
Director name: Mr Michael R Askew
Amount purchased: 35,530 @ 152.00p
Value: £54,006

Standard Life European Private Equity Trust (SEP)
Director name: Mr Clive Sherling
Amount purchased: 20,000 @ 214.50p
Value: £42,900

CBG Group (CB.)
Director name: Mr Martin G Lewis
Amount purchased: 14,870 @ 152.00p
Value: £22,602

Standard Life European Private Equity Trust (SEP)
Director name: Mr Clive Sherling
Amount purchased: 10,000 @ 215.00p
Value: £21,500

Canaccord Capital (CCI)
Director name: Mr Peter MacLachlan Brown
Amount purchased: 2,000 @ 451.40p
Value: £9,028


Top Director Sells
Beazley Group (BEZ)
Director name: Mr Clive Washbourn
Amount sold: 52,416 @ 158.80p
Value: £83,237

Tepnel Life Sciences (TED)
Director name: Mr Don Marvin
Amount sold: 200,000 @ 6.12p
Value: £12,240

Tepnel Life Sciences (TED)
Director name: Mr Don Marvin
Amount sold: 200,000 @ 7.00p
Value: £14,000

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

TED Market Data

Currency UK Pounds
Share Price 12.50p Price Down
Change Today -0.50p
52 Week High 14.50
52 Week Low 7.75
Volume 2,671,823
Shares Issued 233.38m
Market Cap £29.17m
Beta 0.37
RiskGrade 274

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
31.11% below the market average31.11% below the market average31.11% below the market average31.11% below the market average31.11% below the market average
1.27% above the sector average1.27% above the sector average1.27% above the sector average1.27% above the sector average1.27% above the sector average
Price Trend
99.05% above the market average99.05% above the market average99.05% above the market average99.05% above the market average99.05% above the market average
97.75% above the sector average97.75% above the sector average97.75% above the sector average97.75% above the sector average97.75% above the sector average
Income Not Available
Growth
78.49% above the market average78.49% above the market average78.49% above the market average78.49% above the market average78.49% above the market average
88.73% above the sector average88.73% above the sector average88.73% above the sector average88.73% above the sector average88.73% above the sector average
Price Chg 6m
97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average97.24% above the market average
95.51% above the sector average95.51% above the sector average95.51% above the sector average95.51% above the sector average95.51% above the sector average
P/E
54.56% below the market average54.56% below the market average54.56% below the market average54.56% below the market average54.56% below the market average
47.37% below the sector average47.37% below the sector average47.37% below the sector average47.37% below the sector average47.37% below the sector average
PEG
84.70% above the market average84.70% above the market average84.70% above the market average84.70% above the market average84.70% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Dividend Yield Not Available
EPS Growth
98.94% above the market average98.94% above the market average98.94% above the market average98.94% above the market average98.94% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Operating Margin
2.61% above the market average2.61% above the market average2.61% above the market average2.61% above the market average2.61% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

TED Dividends

No dividends found

Trades for 10-Oct-2008

Time Volume / Share Price
13:43 650,000 @ 12.00p
13:43 650,000 @ 12.00p
13:42 7,093 @ 12.00p
12:57 10,000 @ 12.00p
10:49 100,000 @ 12.00p

TED Key Personnel

CEO Ben Matzilevich
Finance Director Michael Keith Slater

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).